Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Burden of bladder cancer across Asia: Insights from the Global Burden of Disease (1999–2023).

View through CrossRef
e16617 Background: Bladder cancer is a malignant neoplasm arising from uncontrolled growth of the urothelial lining and represents an increasing global health concern. This study examines long-term trends in disability-adjusted life years (DALYs) and mortality due to bladder cancer across Asia from 1990 to 2023. Methods: Age-standardized bladder cancer data were obtained from the Global Burden of Disease (GBD) database. Mortality was reported as age-standardized death rates (ASDRs) per 100,000 population. Temporal trends were assessed using joinpoint regression to estimate annual percentage change (APC) and average annual percentage change (AAPC). Results: From 1990 to 2023, age-standardized DALYs declined across most Asian regions. East Asia carried the highest burden but showed a marked reduction, with DALYs decreasing from 70.38 to 40.42 (AAPC −1.59%; 95% CI −2.27 to −0.90; p < 0.001). Significant declines were also observed in Central Asia (57.34 to 40.10; AAPC −1.10%; p = 0.020) and High-income Asia Pacific (49.51 to 43.00; AAPC −0.44%; p < 0.001). South Asia demonstrated only a modest decrease (31.78 to 30.68; AAPC −0.17%; p = 0.042), while Southeast Asia remained relatively stable (26.30 to 28.60; AAPC 0.24%; p = 0.16). ASDRs showed similar patterns. East Asia had the highest mortality rates, declining from 3.20 to 2.03 per 100,000 (AAPC −1.03%; p < 0.001). Central Asia and High-income Asia Pacific also experienced significant reductions, whereas South and Southeast Asia exhibited largely stable trends. Conclusions: Although bladder cancer burden has declined across much of Asia, mortality and DALYs remain substantial. Strengthening early detection, risk-factor control, and preventive strategies remains essential to further reduce disease impact. Trends in bladder cancer burden across Asia (1990–2023). Region DALYs 1990 DALYs 2023 AAPC (%) ASDR trend East Asia 70.38 40.42 −1.59 ↓ Central Asia 57.34 40.10 −1.10 ↓ High-income Asia Pacific 49.51 43.00 −0.44 ↓ South Asia 31.78 30.68 −0.17 ↔ Southeast Asia 26.30 28.60 +0.24 ↔ DALYs and ASDRs are age-standardized per GBD 2023. ↓ indicates significant decline; ↔ indicates stable trend.
Title: Burden of bladder cancer across Asia: Insights from the Global Burden of Disease (1999–2023).
Description:
e16617 Background: Bladder cancer is a malignant neoplasm arising from uncontrolled growth of the urothelial lining and represents an increasing global health concern.
This study examines long-term trends in disability-adjusted life years (DALYs) and mortality due to bladder cancer across Asia from 1990 to 2023.
Methods: Age-standardized bladder cancer data were obtained from the Global Burden of Disease (GBD) database.
Mortality was reported as age-standardized death rates (ASDRs) per 100,000 population.
Temporal trends were assessed using joinpoint regression to estimate annual percentage change (APC) and average annual percentage change (AAPC).
Results: From 1990 to 2023, age-standardized DALYs declined across most Asian regions.
East Asia carried the highest burden but showed a marked reduction, with DALYs decreasing from 70.
38 to 40.
42 (AAPC −1.
59%; 95% CI −2.
27 to −0.
90; p < 0.
001).
Significant declines were also observed in Central Asia (57.
34 to 40.
10; AAPC −1.
10%; p = 0.
020) and High-income Asia Pacific (49.
51 to 43.
00; AAPC −0.
44%; p < 0.
001).
South Asia demonstrated only a modest decrease (31.
78 to 30.
68; AAPC −0.
17%; p = 0.
042), while Southeast Asia remained relatively stable (26.
30 to 28.
60; AAPC 0.
24%; p = 0.
16).
ASDRs showed similar patterns.
East Asia had the highest mortality rates, declining from 3.
20 to 2.
03 per 100,000 (AAPC −1.
03%; p < 0.
001).
Central Asia and High-income Asia Pacific also experienced significant reductions, whereas South and Southeast Asia exhibited largely stable trends.
Conclusions: Although bladder cancer burden has declined across much of Asia, mortality and DALYs remain substantial.
Strengthening early detection, risk-factor control, and preventive strategies remains essential to further reduce disease impact.
Trends in bladder cancer burden across Asia (1990–2023).
Region DALYs 1990 DALYs 2023 AAPC (%) ASDR trend East Asia 70.
38 40.
42 −1.
59 ↓ Central Asia 57.
34 40.
10 −1.
10 ↓ High-income Asia Pacific 49.
51 43.
00 −0.
44 ↓ South Asia 31.
78 30.
68 −0.
17 ↔ Southeast Asia 26.
30 28.
60 +0.
24 ↔ DALYs and ASDRs are age-standardized per GBD 2023.
↓ indicates significant decline; ↔ indicates stable trend.

Related Results

The Burden of Road Traffic Injuries: A Global Perspective
The Burden of Road Traffic Injuries: A Global Perspective
Introduction     Road Traffic Injury (RTI) pose a significant health challenge. It represents the eighth leading cause of death globally, prompting the UN to designate 2011-2020 as...
Spectroscopic and transition properties of SeH<sup>–</sup> anion including spin-orbit coupling
Spectroscopic and transition properties of SeH<sup>–</sup> anion including spin-orbit coupling
<sec>Potential energy curves (PECs), permanent dipole moments (PDMs) and transition dipole moments (TMDs) of five Λ-S states of SeH<sup>−</sup> anion are calculat...
Theoretical study of laser-cooled SH<sup>–</sup> anion
Theoretical study of laser-cooled SH<sup>–</sup> anion
The potential energy curves, dipole moments, and transition dipole moments for the <inline-formula><tex-math id="M13">\begin{document}${{\rm{X}}^1}{\Sigma ^ + }$\end{do...
Purines modulate urinary bladder arteriolar tone
Purines modulate urinary bladder arteriolar tone
Bladder dysfunction affects millions of people, but few effective treatments are available. In humans, changes in bladder function correlate to changes in blood flow. In rodent mod...
Abstract 4948: Bladder cancer incidence: A systematic review and meta-analysis in SSA
Abstract 4948: Bladder cancer incidence: A systematic review and meta-analysis in SSA
Abstract Introduction: Bladder Cancer shows a substantial geographic disparity worldwide (1-3). The highest incidence rates are ...
Urinary bladder wall thickness in type 2 diabetes mellitus patients
Urinary bladder wall thickness in type 2 diabetes mellitus patients
Introduction: Diabetes mellitus is an increasing health challenge with accompanying urological complications. Over 50% of men and women with diabetes have bladder dysfunction. Acco...
Interview: Timothy Clinton
Interview: Timothy Clinton
What has driven you to specialise in urologic oncology, in particular the management of advanced testicular and bladder malignancies? My interest in urology started in medical scho...

Back to Top